Pantium (Pantoprazole)

Pantoprazole, the active ingredient in Pantium, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid production and is used to treat conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adult patients.

GNH USA supplies Pantium as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and procurement teams worldwide. The company adheres to stringent quality standards and regulatory requirements across EU and global markets.

Pantoprazole is indicated for acid‑related gastrointestinal disorders, acting to reduce gastric acidity.

- Gastroesophageal reflux disease (GERD): alleviates heartburn and esophageal irritation by decreasing acid exposure. - Erosive esophagitis: promotes healing of damaged esophageal lining and prevents further erosion. - Peptic ulcer disease: supports ulcer healing and reduces risk of recurrence by suppressing acid secretion.

Pantoprazole may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Headache: mild to moderate headache reported. - Diarrhea: loose stools or increased bowel movements. - Nausea: feeling of queasiness or upset stomach. - Abdominal pain: discomfort or cramps in the stomach area.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis requiring medical attention. - Acute interstitial nephritis: kidney inflammation presenting with reduced urine output. - Severe hypersensitivity reactions: including rash, angioedema or anaphylaxis.

When prescribing Pantoprazole, clinicians should consider several precautionary measures to ensure safe use. - Assess renal function: dose adjustment may be needed in severe impairment. - Monitor for osteoporosis: long‑term use can affect calcium absorption. - Evaluate for hypomagnesemia: prolonged therapy may lower magnesium levels. - Use with caution in hepatic impairment: limited data in severe liver disease. - Review concomitant medications: potential for drug‑drug interactions. - Store at ambient temperature: keep below 25 °C, retain in original packaging and protect from moisture.

Pantoprazole can interact with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Ketoconazole: reduced absorption of ketoconazole due to increased gastric pH. - Atazanavir: decreased plasma concentrations of atazanavir, compromising antiviral efficacy. - Clopidogrel: diminished activation of clopidogrel, potentially lowering antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, requiring closer coagulation monitoring. - Digoxin: may increase serum digoxin levels, necessitating dosage adjustment.